Sign inGet started

STRECK PAUL

Insider CIK 1708063 · INSM Chief Medical Officer · ALBO Chief Medical Officer · ALDR Chief Medical Officer · PEPG EVP, Head of R&D

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PEPG PepGen Inc. S Sale2026-03-042026-03-0647$6.29 $29676,226SEC↗
PEPG PepGen Inc. S Sale2026-03-042026-03-061,832$6.23 $11.4K76,273SEC↗
PEPG PepGen Inc. A Award deriv2026-03-012026-03-02196,500— $0196,500SEC↗
PEPG PepGen Inc. A Award2026-03-012026-03-0250,300— $078,105SEC↗
PEPG PepGen Inc. D To issuer deriv2025-11-042025-12-1840,000— $00SEC↗
PEPG PepGen Inc. A Award deriv2025-11-042025-12-1840,000— $0242,816SEC↗
PEPG PepGen Inc. D To issuer deriv2025-11-042025-12-18202,816— $040,000SEC↗
PEPG PepGen Inc. A Award deriv2025-11-042025-12-18202,816— $0202,816SEC↗
PEPG PepGen Inc. P Buy2025-05-302025-06-028,375$1.24 $10.4K27,805SEC↗
PEPG PepGen Inc. A Award deriv2025-03-032025-03-0587,000— $087,000SEC↗
PEPG PepGen Inc. A Award2025-03-032025-03-0519,430— $019,430SEC↗
PEPG PepGen Inc. A Award deriv2024-08-192024-08-2040,000— $0242,816SEC↗
PEPG PepGen Inc. A Award deriv2024-08-192024-08-20202,816— $0202,816SEC↗
ALBO ALBIREO PHARMA, INC. D To issuer deriv2023-03-022023-03-02118,966— $00SEC↗
ALBO ALBIREO PHARMA, INC. A Award2023-01-192023-01-2555,000— $0118,966SEC↗
ALBO ALBIREO PHARMA, INC. A Award2023-01-192023-01-2755,000— $0118,966SEC↗
ALBO ALBIREO PHARMA, INC. A Award2022-12-192022-12-2163,966— $063,966SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-24250,000— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer2019-10-222019-10-241,390$18.00 $25.0K0SEC↗
ALDR ALDER BIOPHARMACEUTICALS I A Award2019-10-112019-10-241,390$9.20 $12.8K1,390SEC↗
ALDR ALDER BIOPHARMACEUTICALS I A Award deriv2019-01-212019-01-23250,000— $0250,000SEC↗
ALDR ALDER BIOPHARMACEUTICALS I A Award deriv2019-01-212019-02-01250,000— $0250,000SEC↗
INSM INSMED Inc A Award2018-08-082018-08-094,506— $015,996SEC↗
INSM INSMED Inc A Award deriv2018-01-042018-01-0859,660— $059,660SEC↗
INSM INSMED Inc A Award2018-01-042018-01-0811,490— $011,490SEC↗
INSM INSMED Inc A Award deriv2017-06-052017-06-07109,210— $0109,210SEC↗